Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN

被引:9
作者
Deeb, Omar [1 ]
Jawabreh, Sana [1 ]
Goodarzi, Mohammad [2 ]
机构
[1] Al Quds Univ, Fac Pharm, Jerusalem, Israel
[2] Islamic Azad Univ, Arak Branch, Young Researchers Club, Arak, Markazi, Iran
关键词
Vascular endothelial growth factor receptor-2 (VEGFR-2); quantitative structure-activity relationship; Principal component artificial neural network (PC-ANN); Multiple linear regression (MLR) and Partial least square (PLS); PRINCIPAL COMPONENT REGRESSION; ANTI-ANGIOGENIC AGENTS; PYRIDINE BIHETEROARYLS; CANCER-THERAPY; QSPR METHODS; PREDICTION; DISCOVERY; POTENT; BEVACIZUMAB; DESIGN;
D O I
10.2174/1381612811319120010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quantitative structure-activity relationship study was performed to understand the inhibitory activity of a set of 192 vascular endothelial growth factor receptor-2 (VEGFR-2) compounds. QSAR models were developed using multiple linear regression (MLR) and partial least squares (PLS) as linear methods. While principal component - artificial neural networks (PC-ANN) modeling method with application of eigenvalue ranking factor selection procedure was used as nonlinear method. The results obtained offer good regression models having good prediction ability. The results obtained by MLR and PLS are close and better than those obtained by principal component-artificial neural network. The best model was obtained with a correlation coefficient of 0.87. The strength and the predictive performance of the proposed models was verified using both internal (cross-validation and Y-scrambling) and external statistical validations.
引用
收藏
页码:2237 / 2244
页数:8
相关论文
共 45 条
[1]  
[Anonymous], NATURE
[2]   Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor [J].
Bhide, RS ;
Cai, ZW ;
Zhang, YZ ;
Qian, LG ;
Wei, D ;
Barbosa, S ;
Lombardo, LJ ;
Borzilleri, RM ;
Zheng, XP ;
Wu, LI ;
Barrish, JC ;
Kim, SH ;
Leavitt, K ;
Mathur, A ;
Leith, L ;
Chao, S ;
Wautlet, B ;
Mortillo, S ;
Jeyaseelan, R ;
Kukral, D ;
Hunt, JT ;
Kamath, A ;
Fura, A ;
Vyas, V ;
Marathe, P ;
D'Arienzo, C ;
Derbin, G ;
Fargnoli, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (07) :2143-2146
[3]   Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel [J].
Bilodeau, MT ;
Balitza, AE ;
Koester, TJ ;
Manley, PJ ;
Rodman, LD ;
Buser-Doepner, C ;
Coll, KE ;
Fernandes, C ;
Gibbs, JB ;
Heimbrook, DC ;
Huckel, WR ;
Kohl, N ;
Lynch, JJ ;
Mao, XZ ;
McFall, RC ;
McLoughlin, D ;
Miller-Stein, CM ;
Rickert, KW ;
Sepp-Lorenzino, L ;
Shipman, JM ;
Subramanian, R ;
Thomas, KA ;
Wong, BK ;
Yu, S ;
Hartman, GD .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6363-6372
[4]   Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agents [J].
Bilodeau, MT ;
Fraley, ME ;
Hartman, GD .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (06) :737-745
[5]   Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo-[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors [J].
Borzilleri, RM ;
Cai, ZW ;
Ellis, C ;
Fargnoli, J ;
Fura, A ;
Gerhardt, T ;
Goyal, B ;
Hunt, JT ;
Mortillo, S ;
Qian, LG ;
Tokarski, J ;
Vyas, V ;
Wautlet, B ;
Zheng, XP ;
Bhide, RS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) :1429-1433
[6]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[7]   ANN-QSAR model of drug-binding to human serum albumin [J].
Deeb, Omar ;
Hemmateenejad, Bahrarn .
CHEMICAL BIOLOGY & DRUG DESIGN, 2007, 70 (01) :19-29
[8]   Effect of the electronic and physicochemical parameters on the carcinogenesis activity of some sulfa drugs using QSAR analysis based on genetic-MLR and genetic-PLS [J].
Deeb, Omar ;
Hemmateenejad, Bahram ;
Jaber, Amal ;
Garduno-Juarez, R. ;
Miri, Ramin .
CHEMOSPHERE, 2007, 67 (11) :2122-2130
[9]   Quantum Chemical QSAR Models to Distinguish Between Inhibitory Activities of Sulfonamides Against Human Carbonic Anhydrases I and II and Bovine IV Isozymes [J].
Deeb, Omar ;
Goodarzi, Mohammad ;
Khadikar, Padmaker V. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (04) :514-522
[10]   Prediction of melting point for drug-like compounds via QSPR methods [J].
Deeb, Omar ;
Goodarzi, Mohammad ;
Alfalah, Sherin .
MOLECULAR PHYSICS, 2011, 109 (04) :507-516